International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (November 4-6, 2019 - Copenhagen, Denmark).
Clicks: 435
ID: 71171
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
78.7
/100
435 views
275 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #4 of 29 articles by views in drugs of today (barcelona, spain : 1998)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
With 2019 shaping up to be another significant year for health economics and outcomes research, and increasingly innovative health technologies affecting both the cost and impact of healthcare decisions, rapid change is affecting healthcare systems in real time. The theme of this year's International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe annual meeting was centered on digital transformation of healthcare; over 4,000 attendees from over 90 countries spent the day in the discussion of the changing roles and shared responsibilities of increased digitization, which involves major changes not only in technology but also in the way care is organized and delivered.
| Reference Key |
kibble2019internationaldrugs
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Kibble, A; |
| Journal | drugs of today (barcelona, spain : 1998) |
| Year | 2019 |
| DOI |
10.1358/dot.2019.55.11.3100502
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.